Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > How do you rate TLD1433's POS, Dr. Madzarevic?

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Nov 18, 2021 2:58pm

705 Views

Post# 34142253

RE:RE:How do you rate TLD1433's POS, Dr. Madzarevic?

I think so too. It was a rhetorical question.

newdaydawning wrote: I think the answer to the question is self evident. Vera joined TLT because she saw TLD-1433 as having a high probability of success. There really is no other plausible explanation.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023